Portfolio company
ARMO BioSciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology firm develops immunotherapy medicines to activate the immune systems of cancer patients to recognise and eradicate tumours.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Arcus Biosciences
This biopharmaceutical company develops molecules and combination therapies for patients with various forms of cancer and immune diseases.
Actym Therapeutics
This biotechnology company develops bacterial immunotherapies to treat solid tumours and fibrotic diseases for patients with advanced cancers.
Jounce Therapeutics
This clinical-stage biopharmaceutical company develops immunotherapy treatments for cancer patients by using a platform that enables the immune system to attack tumours.
Xilio Therapeutics
This biotechnology company develops tumour-activated immuno-oncology therapies designed to treat patients with solid cancers while reducing systemic side effects.
Arch Oncology
This biotechnology firm develops antibody therapies to treat patients with solid tumours and hematologic malignancies.
Ventuno Biotech
This biotechnology company develops cancer immunotherapies to stimulate the immune system and treat patients with difficult tumours.
Bioarchitech
This company develops viral and RNA immunotherapies designed to help the immune systems of cancer patients target and destroy tumours.
Avenge Bio
This biotechnology firm develops cell-based immunotherapies for patients with solid tumours, specifically targeting metastatic peritoneal cancers like ovarian cancer.
